Skip to content

ATLANTIS:Extensive Type A Dissections and Thoracic/ Thoraco-Abdominal Aneurysms Repair With LupiAe Hybrid TechNique

Extensive Type A Dissections and Thoracic/ Thoraco-Abdominal

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01107366
Acronym
ATLANTIS
Enrollment
120
Registered
2010-04-21
Start date
2010-06-30
Completion date
2012-12-31
Last updated
2011-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm

Keywords

lupiae techinque, aortic aneurism, aortic dissection

Brief summary

To prospectively evaluate the safety and efficacy of the LUPIAE hybrid technique for the treatment of * thoracic or thoraco-abdominal aortic aneurysms * thoracic aortic type A dissections 2. to compare the safety and efficacy of the LUPIAE hybrid technique with historical groups (literature review, other hybrid techniques, LUPIAE retrospective patients)

Detailed description

LUPIAE technique: Hybrid repair of thoracic or thoraco-abdominal aneurysms of different etiology and type A dissections with a two-stage procedure: 1. surgical arch reconstruction with a Dacron multibranched surgical prothesis 2. endovascular implantation of a thoracic stent graft

Interventions

PROCEDURElupiae technique

it's a new hybrid technique for the treatment of aortic aneurism and dissection.

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient willing to sign the informed consent, or In case of acute patients that should arrive at the hospital in unconsciousness status, patient's first degree relatives willingness to sign the informed consent and patient's willingness to re-consent for the study participation once he/she is again conscious. and 2. Patients with extensive thoracic or thoraco-abdominal aortic aneurysms (\>55 mm diameter), involving the ascending, arch and descending aortic segments, but not involving the renal arteries (at least 15 mm of healthy tissue above the most proximal renal artery). Or 3. Patients with extensive type A aortic dissection (DeBakey type I) with at least one of the following minimum criteria: * An initial false lumen diameter measured in the upper descending thoracic aorta \>22 mm; * Total aortic diameter measured in the descending thoracic aorta \>45 mm; * True lumen's compression (True lumen \<10% of total aortic lumen); * Non-controlled hypertension; * Persistent pain; * Rupture or imminent rupture;

Exclusion criteria

1. Patient has a standard contraindication to the implant of thoracic stent graft; 2. Patient unable to commit to follow-up schedule; 3. Patient has medical conditions that preclude protocol required testing or limit study participation; 4. Patient is enrolled or intend to participate in another clinical trial during the course of this study; 5. Less than 18 years of age; 6. Pregnancy; 7. A life expectancy of less than one year, except for Patients with extensive type A aortic dissection (DeBakey type I)

Design outcomes

Primary

MeasureTime frame
all cause mortality12 months

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026